Pulmonx Corporation LUNG
Set alert
2.58 USD -0.42 -14.14%
At close
2.58 0.00 0.00%
Pre-market · Nov 3, 6:59 AM ET
2.50 Day range 3.13
1.13 52-week range 3.25
- YTD
- +16.74%
- 1 year
- +29.00%
- Open
- 3.04
- Prev close
- 3.01
- Mkt cap
- 108.97M
- Vol
- 1.44M
- Avg vol
- 618.00K
- EPS
- -1.01
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 2.50
- High
- 3.13
- Forward P/E
- -3.91
- Beta
- 0.68
- Short ratio
- 3.62
- Inst. own
- 94.86%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Jul 31, 2024
- 50-d avg
- 6.51
- 200-d avg
- 7.33
- 1y target
- 11.92
6M chart
Signals (32)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Oct 28, 2026 | 5 days ago |
| RSI: Overbought | Oct 28, 2026 | 5 days ago |
| SMA: Bullish | Oct 20, 2026 | 1 week ago |
| MACD: Buy Signal | Oct 20, 2026 | 1 week ago |
| SMA: Bearish | Oct 19, 2026 | 2 weeks ago |
| SMA: Bearish | Sep 24, 2026 | 1 month ago |
| SMA: Bullish | Sep 14, 2026 | 1 month ago |
| SMA: Bearish | Sep 10, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 28, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 25, 2026 | 2 months ago |
| RSI: Overbought | Aug 25, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 24, 2026 | 2 months ago |
| RSI: Overbought | Aug 14, 2026 | 2 months ago |
| RSI: Overbought | Aug 6, 2026 | 2 months ago |
| RSI: Overbought | Aug 3, 2026 | 3 months ago |
| SMA: Bullish | Jul 30, 2026 | 3 months ago |
| SMA: Bullish | Jul 30, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 30, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 20, 2026 | 3 months ago |
| SMA: Bearish | Jul 17, 2026 | 3 months ago |
Newest 20 of 32.
Analyst view
Consensus: buy
Buy
Price target (mean) 11.92 +361.9% upside
Now 2.58
- Target (low)
- 7.50
- Target (mean)
- 11.92
- Target (high)
- 16.00
Ratings (0m) 6 4 buy · 2 hold · 0 sell
- Strong buy1
- Buy3
- Hold2
- Sell0
- Strong sell0
Recommendation trend
- This month 6
- 1 month ago 6
- 2 months ago 6
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.44894 | -0.47 – -0.41 | -0.36 | -24.7% | 22.29M | +15.6% | 5 |
| Next quarter | -0.39623 | -0.45 – -0.35 | -0.36 | -10.1% | 22.23M | +17.9% | 5 |
| Current year | -1.56 | -1.58 – -1.52 | -1.60 | +2.5% | 82.32M | +19.9% | 5 |
| Next year | -1.58 | -1.81 – -1.43 | -1.56 | -1.3% | 97.72M | +18.7% | 5 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 11, 2024 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Dec 11, 2024 | Citigroup | Downgrade | Buy | Neutral |
| Oct 31, 2024 | Stifel | Maintained | Buy | Buy |
| Aug 1, 2024 | Piper Sandler | Maintained | Overweight | Overweight |
| Aug 1, 2024 | Canaccord Genuity | Maintained | Buy | Buy |
| Aug 1, 2024 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Jun 4, 2024 | Lake Street | Initiated | — | Buy |
| May 2, 2024 | Canaccord Genuity | Maintained | Buy | Buy |
| Apr 3, 2024 | Piper Sandler | Reiterated | Overweight | Overweight |
| Feb 23, 2024 | Citigroup | Maintained | Buy | Buy |
| Feb 23, 2024 | Wells Fargo | Downgrade | Overweight | Equal-Weight |
| Feb 22, 2024 | Stifel | Maintained | Buy | Buy |
| Feb 22, 2024 | Piper Sandler | Maintained | Overweight | Overweight |
| Feb 22, 2024 | Wells Fargo | Maintained | Overweight | Overweight |
| Oct 31, 2023 | Piper Sandler | Maintained | Overweight | Overweight |
| Oct 31, 2023 | Canaccord Genuity | Maintained | Buy | Buy |
| Sep 5, 2023 | Craig-Hallum | Initiated | — | Buy |
| Aug 3, 2023 | Piper Sandler | Maintained | Overweight | Overweight |
| Jul 11, 2023 | Citigroup | Maintained | Buy | Buy |
| May 3, 2023 | Citigroup | Maintained | — | Buy |
| May 3, 2023 | Piper Sandler | Maintained | — | Overweight |
| May 3, 2023 | Morgan Stanley | Maintained | — | Equal-Weight |
| Apr 3, 2023 | Citigroup | Maintained | — | Buy |
| Feb 27, 2023 | Wells Fargo | Upgrade | Equal-Weight | Overweight |
| Feb 24, 2023 | Citigroup | Maintained | — | Buy |
| Feb 23, 2023 | Canaccord Genuity | Maintained | — | Buy |
| Feb 23, 2023 | Morgan Stanley | Maintained | — | Equal-Weight |
| Jan 6, 2023 | Morgan Stanley | Maintained | — | Equal-Weight |
| Jan 3, 2023 | B of A Securities | Downgrade | Neutral | Underperform |
| Dec 12, 2022 | Wells Fargo | Maintained | — | Equal-Weight |